Medical/Pharmaceuticals

Preserving Tradition in the Digital Age: A Historic Collaboration for Digitising Bhutan's Medicinal Plants and Herbs

NEW YORK and SINGAPORE, Nov. 20, 2023 /PRNewswire/ -- In a landmark move, four eminent organisations have united under a Memorandum of Understanding (MOU) signed on17 November 2023. This alliance aims to digitise and certify Bhutan's treasured Sowa-Rigpa, the ancient Traditional Medicines know...

2023-11-20 22:00 2850

CARsgen Announces Formation of its Clinical Advisory Board

SHANGHAI, Nov. 20, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces the formation of its Clinical Advisory Board. This highly regarded pa...

2023-11-20 21:50 3807

Porton Advanced and Ascle Therapeutics Reached a Strategic Partnership to Promote the Application of NK Cells in Cancer Prevention, Beauty, and Anti-aging

SUZHOU, China, Nov. 20, 2023 /PRNewswire/ -- On November 20, 2023, Porton Advanced announced a strategic partnership with Ascle Therapeutics to jointly develop and produce NK cells, assist in the development and innovation in gene and cell therapy, and accelerate the application of NK cells in ca...

2023-11-20 20:00 2119

First Subject Enrolled in Phase 1 Study of MRX-5

SHANGHAI, Nov. 20, 2023 /PRNewswire/ -- Recently, Shanghai MicuRx Pharmaceuticals Co., Ltd. (hereinafter referred to as "MicuRx") announced that its proprietary antibiotic MRX-5, has enrolled its first subject in the first Phase I clinical trial inAustralia. MRX-5 is a new type of benzodiazepine...

2023-11-20 18:34 2451

GCCL Wins Top 10 Bioanalytical Services Providers in APAC 2023

Recognized for its global-quality sample analysis services based on various analytical platforms YONGIN, South Korea, Nov. 20, 2023 /PRNewswire/ -- GCCL, a Korean clinical trial sample analysis company, announced onNovember 20th that it has been selected as the Top 10 Bioanalytical Services Prov...

2023-11-20 14:39 2274

Sanyou's "STAL Platform" is a significant advancement in the field of drug discovery.

SHANGHAI, Nov. 17, 2023 /PRNewswire/ -- Sanyou's "STAL Innovative Biologics Drug Discovery Platform" is a significant advancement in the field of drug discovery. This cutting-edge platform enables the screening of thousands of innovative lead molecules against a common target, surpassing the capa...

2023-11-18 08:00 3914

CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update

Conference call webcast is scheduled for November 22 at 9 a.m. ET. SINGAPORE, Nov. 17, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore -based biopharmaceutical company focused on harnessing its proprietary technologie...

2023-11-17 22:21 4699

Meihua International Medical Technologies Co. Unveils Speed Fox, a Cutting-Edge AI-Powered Warehouse Management and Medical Device Logistics Platform

YANGZHOU, China, Nov. 17, 2023 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries inChina, announced today the upcoming la...

2023-11-17 21:00 2410

Taiwan Lubricate for academic research and health products development

TAICHUNG, Nov. 17, 2023 /PRNewswire/ -- Based in Taiwan, T-BAL is the leading service provider in measurements of lipids and metabolites for both academics and industry. In the collaboration with Lipotype GmbH,Germany (the world leader in lipidomics profiling service), T-BAL has developed advance...

2023-11-17 20:00 1841

Singleron Biotechnologies announces two co-authored abstracts at the American Society of Hematology conference

Using single cell multi-omics analysis to predict treatment outcome, develop disease prognostics and track patient responses to CAR T therapies COLOGNE, Germany, Nov. 17, 2023 /PRNewswire/ -- Singleron Biotechnologies , a company at the forefront of developing and commerc...

2023-11-17 17:58 2333

epitoMAP Inc., Animal Allergy Clinical Laboratories Inc. and Nippon Zenyaku Kogyo Co., Ltd. Enter into License Agreement

SAGAMIHARA, Japan, Nov. 17, 2023 /PRNewswire/ -- epitoMAP Inc. (hereinafter "epitoMAP") and Animal Allergy Clinical Laboratories Inc. (hereinafter "AACL") entered into a License Agreement for an antibody pharmaceutical for veterinary use, CRE-DR-B, with Nippon Zenyaku Kogyo Co., Ltd. (hereinafter...

2023-11-17 16:00 2356

WuXi XDC Successfully Listed on the Main Board of Hong Kong Stock Exchange

HONG KONG, Nov. 17, 2023 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC" or the "Company", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization ("CRDMO") focused on antibody drug conjugates ("ADC") and the broader bioconjugate market, listed on the...

2023-11-17 14:00 4336

Lunit to Implement AI-Powered Chest Screening Solution in Five Major Saudi Hospitals

-    Lunit brings Lunit INSIGHT CXR to five major Saudi hospitals, aiming to enhance early detection of common lung abnormalities and improve patient outcomes in line with the national health strategy SEOUL, South Korea, Nov. 16, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of ...

2023-11-16 22:00 2980

Once-Weekly TransCon™ CNP Achieved Primary Efficacy Objective in ACcomplisH China Phase 2 Trial

SHANGHAI, Nov. 16, 2023 /PRNewswire/ -- VISEN Pharmaceuticals (VISEN), an innovative biopharmaceutical company focused on endocrine diseases, is pleased to announce the topline results from the ACcomplisH China Phase 2 Trial in children with achondroplasia (ACH) aged 2 to 10 years. In the trial, ...

2023-11-16 22:00 2583

Heuron to Participate in RSNA 2023, Showcasing Neuro AI Solutions and Presenting Abstract on AI Solutions for Stroke

SEOUL, South Korea, Nov. 16, 2023 /PRNewswire/ -- Heuron, a medical AI (artificial intelligence) imaging software solution company, under the leadership of CEO Dr.Donghoon Shin, is scheduled to take part in the 2023 Radiological Society ofNorth America (RSNA) conference, scheduled for this month...

2023-11-16 21:00 2513

ACROBiosystems launches GMP-grade DLL4 Protein to accelerate stem cell manufacturing

NEWARK, Del., Nov. 16, 2023 /PRNewswire/ -- ACROBiosystems, a global cornerstone of the pharmaceutical industry committed to offering innovative tools and solutions, recently announces the launch of GMP grade DLL4. GMP grade DLL4 is a recombinant, soluble form of Delta-like Ligand 4, or DLL4, ...

2023-11-16 20:08 2496

Lunit Secures $150 Million in Capital Increase

* Fund fully paid-in as of November 9, achieving over 100% shareholder participation SEOUL, South Korea, Nov. 15, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the successful completion of a signi...

2023-11-15 22:00 2885

CCHIO, a Milestone Event for the Global Cancer Community, Returns to Tianjin in 2023

Bringing together expertise to pool wisdom in China and around the world. TIANJIN, China, Nov. 15, 2023 /PRNewswire/ -- The 2023 edition of the Chinese Congress of Holistic Integrative Oncology will be held fromNovember 16th to 19th in Tianjin,China. Organized by the China Anti-Cancer Association...

2023-11-15 15:10 2408

Riding the tide, realize the future: The BD paths for Chinese Biotech

WUXI, China, Nov. 14, 2023 /PRNewswire/ -- 2023 BIO-Europe just closed last week. In line with previous conferences, this BD carnival attracted more than 2,000 companies, 5,000 attendees from close to 60 countries all over the world. Recently, we interviewed a global BD expert, Dr. Kaan Certel.  ...

2023-11-15 10:42 1924

EDAN's Focus on Medical Technology Advancement Shines at MEDICA 2023

DUSSELDORF, Germany, Nov. 14, 2023 /PRNewswire/ -- Edan Instruments Inc. (300206.SZ), a leading global provider of medical and healthcare solutions, showcased its innovative range of new products at MEDICA 2023 inGermany. This grand event, anticipated to draw over 81,000 v...

2023-11-14 22:31 5156
1 ... 158159160161162163164 ... 264